Business and Asset Acquisitions (Tables)

6 Months Ended

Jun. 30, 2018

PhotoMedex [Member]

Schedule of Pro Forma Financial Information

	For the three months ended June 30,						For the six months ended June 30,
	2018			2017			2018			2017
Net sales	$	7,012,056		$	7,950,076		$	15,982,862		$	19,136,195
Net loss	$	(718,569	)	$	(1,440,680	)	$	(718,499	)	$	(1,501,986	)
Net loss per share – basic and diluted	$	(0.01	)	$	(0.03	)	$	(0.01	)	$	(0.03	)
Weighted average number of common shares basic and diluted		52,417,623			52,075,703			53,379,374			48,093,572

Ermis Labs [Member]

Schedule of Deferred Consideration

The changes in the Company’s deferred consideration payable due to Ermis Labs, Inc. during the six months ended June 30, 2018:

Balance at December 31, 2017	$	1,212,067
Consideration payments		(160,414	)
Accretion of interest		47,018
Balance at June 30, 2018-related party	$	1,098,671
Current portion	$	143,100
Non-current portion		955,571
	$	1,098,671